Actively Recruiting
Molecular Study of Migraine Patients and Healthy Controls by Measuring CGRP Levels in Saliva and Blood Tests for DNA and Hormones
Led by Hospital Universitari Vall d'Hebron Research Institute · Updated on 2024-11-13
440
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are studying migraine patients and healthy controls to understand differences in CGRP levels, a neuropeptide linked to migraine. The study aims to explore how these differences relate to treatment responses by examining saliva and blood samples. Participants include males and females aged 6 to 75 years, with and without migraine, to compare molecular profiles. Participants will visit the study center twice the first visit involves clinical assessment for migraine patients, and the second visit is for collecting saliva and blood samples. Healthy controls only attend the sample collection visit. The saliva samples will be tested for CGRP levels, while blood samples will be used for DNA and hormone testing. During the study, researchers will measure CGRP levels, hormone levels, and DNA markers over about one year. Participants health and sample collection will be monitored to support understanding of migraine biology. The total participation involves up to two study visits focused on assessments and sample collection, with no treatment administered during the study.
CONDITIONS
Brief Title
Molecular Phenotyping of Migraine Patients According to Sex and Age Through CGRP Quantification
Research Team
P
Patricia Pozo-Rosich, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
